KK
DYN icon

KLP Kapitalforvaltning’s Dyne Therapeutics DYN Stock Holding History

KLP Kapitalforvaltning’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$564K Hold
25,400
– – ﹤0.01% 1460
2026
Q1 		$461K Hold
25,400
– – ﹤0.01% 1461
2025
Q4 		$497K Buy
25,400
+5,600
+28% +$106K ﹤0.01% 1420
2025
Q3 		$250K Buy
19,800
+4,600
+30% +$52.5K ﹤0.01% 1726
2025
Q2 		$145K Buy
15,200
+4,300
+39% +$47.3K ﹤0.01% 1901
2025
Q1 		$114K Hold
10,900
– – ﹤0.01% 1972
2024
Q4 		$257K Buy
+10,900
New +$322K ﹤0.01% 1713

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

KLP Kapitalforvaltning's DYN Position: Q2 2026 in Review

KLP Kapitalforvaltning held its Dyne Therapeutics (DYN) position steady in Q2 2026 at 25,400 shares worth $564K. The position accounts for ﹤0.01% of the portfolio, ranked #1460.

KLP Kapitalforvaltning first reported a position in DYN in Q4 2024 and has held it in 7 quarters since. 246 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • KLP Kapitalforvaltning held 25,400 shares of Dyne Therapeutics worth $564K as of Q2 2026.
  • KLP Kapitalforvaltning left its Dyne Therapeutics share count unchanged in Q2 2026.
  • Dyne Therapeutics made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #1460 holding.
  • KLP Kapitalforvaltning first reported a position in Dyne Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 246 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.